Clinical Research Directory
Browse clinical research sites, groups, and studies.
Hip Arthroscopy Postoperative Opioid Demands
Sponsor: Rush University Medical Center
Summary
This study will be a prospective, single-blinded, randomized controlled trial (RCT), investigating the influence of the number of opioid pills prescribed following primary hip arthroscopy. All patients who sign the consent form will be enrolled in the suited and randomized to one of the two treatment arms. The intervention group will receive 5 Norco pills, gabapentin (30 mg, once daily for 10 days following surgery), and Tylenol (1000 mg, three times daily for 10 days following surgery) while the control will receive the standard at our practice of 30 Norco pills.
Official title: Randomized Control Trial Evaluating Postoperative Opioid Demands Following Hip Arthroscopy
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
170
Start Date
2020-10-21
Completion Date
2027-03
Last Updated
2025-08-07
Healthy Volunteers
Yes
Interventions
Control Group Regimen
Norco (hydrocodone-acetaminophen) 5mg-325mg, 30 total pills. This is the standard of care prescribing procedure for pain management after hip arthroscopy.
Opioid reduced regimen
Tylenol extra strength (1000 mg, three times daily for 10 days following surgery), Gabapentin (300 mg at night for 10 days following surgery) and Norco (hydrocodone-acetaminophen) 5mg-325mg, 5 total pills
Locations (1)
Rush University Medical Center
Chicago, Illinois, United States